Connection
Michael Mitchell to Autoimmune Diseases
This is a "connection" page, showing publications Michael Mitchell has written about Autoimmune Diseases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.511 |
|
|
|
-
Nachod BE, Thatte AS, Palanki R, Mitchell MJ. Nanoparticle-Based Tolerogenic Vaccines: Next-Generation Strategies for Autoimmune and Allergic Disease Therapies. Angew Chem Int Ed Engl. 2026 02 02; 65(6):e24097.
Score: 0.689
-
Thatte AS, Weaver JD, Pearson R, Mitchell MJ. Drug delivery technologies for autoimmunity therapies. Adv Drug Deliv Rev. 2024 09; 212:115412.
Score: 0.624
-
Thatte AS, Billingsley MM, Weissman D, Melamed JR, Mitchell MJ. Emerging strategies for nanomedicine in autoimmunity. Adv Drug Deliv Rev. 2024 04; 207:115194.
Score: 0.605
-
Thatte AS, Hamilton AG, Nachod BE, Mukalel AJ, Billingsley MM, Palanki R, Swingle KL, Mitchell MJ. mRNA Lipid Nanoparticles for Ex Vivo Engineering of Immunosuppressive T Cells for Autoimmunity Therapies. Nano Lett. 2023 11 22; 23(22):10179-10188.
Score: 0.593